Skandinaviska Enskilda Banken Ab (Publ) Legend Biotech Corp Transaction History
Skandinaviska Enskilda Banken Ab (Publ)
- $21.6 Billion
- Q4 2024
A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Legend Biotech Corp stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 3,100 shares of LEGN stock, worth $106,268. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,100
Previous 12,300
74.8%
Holding current value
$106,268
Previous $599,000
83.31%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding LEGN
# of Institutions
232Shares Held
85.1MCall Options Held
260KPut Options Held
387K-
Ra Capital Management, L.P. Boston, MA7.51MShares$257 Million3.96% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.81MShares$233 Million0.03% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$205 Million7.45% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$196 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.71MShares$196 Million0.86% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.74B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...